Table 3.
Sample No. | Sample | HNA specificity | NBG ratio per bead |
||||||
---|---|---|---|---|---|---|---|---|---|
1a | 1b | 1c | 2 | 3a | 3b | 4a | |||
1–4 | references | 1a | 42.2–60.5 | ||||||
5–10 | references | 1b | 36.7–180.0 | 22.9–202.0 | |||||
11 | reference | 1b | 36.7 | 31.0 | 30.5 | ||||
12 | reference | 1c | 135.9 | ||||||
13 | reference | 2 | 202.0 | 274.5 | |||||
14–17 | references | 2 | 66.3–407.0 | ||||||
18–21 | references | 3a | 186.2–350.4 | 15.0–111.1 | |||||
22–25 | references | 3a | <5.0 | ||||||
26–28 | references | 3a | 57.9–149.9 | ||||||
29, 30 | references | 3b | <5.0 | ||||||
31, 32 | references | 3b | 15.7–58.8 | ||||||
33 | reference | 4a | 10.0 | ||||||
34–36 | donors | none | 6.0–37.7 | ||||||
37, 38 | donors | 2 | 188.3–317.0 | ||||||
39 | donor | none | 48.4 | ||||||
40 | donor | 3a | 22.2 | ||||||
41 | donor | HLA class I | 33.8 | ||||||
42, 43 | donors | none | 16.8–16.9 | ||||||
44 | donor | none | 49.4 | ||||||
45 | donor | unknown | 40.7 |
HNA, human neutrophil antigen; HLA, human leukocyte antigen; NBG, normalized background.